Sleep Disorder Unit, Pitié-Salpêtrière Hospital, Centre de Recherche de l'Institut du Cerveau et de la Moëlle épinière - Pierre and Marie Curie University; Inserm UMR_S 975; CNRS UMR 7225, Paris, France.
Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Mental Health Centre, Guangzhou 510120, China.
Sleep. 2014 Jan 1;37(1):127-36. doi: 10.5665/sleep.3322.
Arousal disorders may have serious health consequences.
To develop a scale assessing the severity of arousal disorders (Paris Arousal Disorders Severity Scale, PADSS).
University hospital.
Controlled study.
Consecutive patients (older than 15 y), with sleepwalking (SW) and/or sleep terrors (ST), subjects with previous SW/ST, normal controls and patients with rapid eye movement sleep behavior disorder.
The self-rated scale listed 17 parasomniac behaviors (PADSS-A), assessed their frequency from never to twice or more per night (PADSS-B) and evaluated the consequences (PADSS-C: disturbed sleep, injuries, fatigue, and psychological consequences). The clinimetric properties and face validity of the scale were tested.
Half of the 73 patients with SW/ST (more men than women) had injured themselves or others, whereas 15% had concomitant sexsomnia and 23% had amnestic eating behaviors. The total PADSS score (range: 0-50) was 19.4 ± 6.3 (range: 8-36) in this group, 11.7 ± 5.9 in 26 subjects with previous SW/ST, 8.8 ± 3.2 in 26 patients with RBD, and 2.0 ± 3.5 in 53 normal controls (P < 0.05). The PADSS demonstrated high sensitivity (83.6%), specificity (87.8%), internal consistency, and test-retest reliability (0.79). The best cutoff for the total score was at 13/14. Exploratory factor analysis revealed two components: wandering and violence/handling. The complexity of behaviors emerging from N3 sleep (scored on videopolysomnography) positively correlated with scores for the PADSS-total, PADSS-A, PADSS-C, and the "violence/handling" factor.
This scale had reasonable psychometric properties and could be used for screening and stratifying patients and for evaluating the effects of treatments.
觉醒障碍可能会带来严重的健康后果。
开发一种评估觉醒障碍严重程度的量表（巴黎觉醒障碍严重程度量表，PADSS）。
大学医院。
对照研究。
连续患者（年龄大于 15 岁），包括梦游症（SW）和/或睡惊症（ST）、有 SW/ST 既往史的患者、正常对照者和快速眼动睡眠行为障碍患者。
自我评估量表列出了 17 种睡眠障碍行为（PADSS-A），评估其从从不至每晚两次或更多次的频率（PADSS-B），并评估其后果（PADSS-C：睡眠障碍、受伤、疲劳和心理后果）。对量表的临床计量特性和表面效度进行了测试。
SW/ST 组的 73 例患者中，有一半的患者曾伤害过自己或他人，15%的患者伴有性睡眠行为障碍，23%的患者有健忘性进食行为。该组的总 PADSS 评分（范围：0-50）为 19.4 ± 6.3（范围：8-36），26 例有 SW/ST 既往史的患者为 11.7 ± 5.9，26 例 RBD 患者为 8.8 ± 3.2，53 例正常对照者为 2.0 ± 3.5（P<0.05）。PADSS 表现出较高的灵敏度（83.6%）、特异性（87.8%）、内部一致性和重测信度（0.79）。总得分的最佳截断值为 13/14。探索性因子分析显示有两个成分：游走和暴力/处理。N3 睡眠（视频多导睡眠图评分）中出现的行为复杂性与 PADSS-总分、PADSS-A、PADSS-C 和“暴力/处理”因子的评分呈正相关。
该量表具有合理的心理计量学特性，可用于筛选和分层患者，并评估治疗效果。
